Brevan Howard Capital Management LP Johnson & Johnson Transaction History

Brevan Howard Capital Management LP

  • $13.9 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$145.48 - $167.38 $1.14 Million - $1.31 Million
-7,825 Reduced 29.1%
19,061 $3.09 Million
Q2 2024

Aug 14, 2024
BUY
$144.38 - $157.78 $3.14 Million - $3.44 Million
21,779 Added 426.45%
26,886 $3.93 Million
Q1 2024

May 15, 2024
BUY
$155.22 - $162.74 $792,708 - $831,113
5,107 New
5,107 $807,000

Others Institutions Holding JNJ

# of Institutions
4,473
Shares Held
1.73B
Call Options Held
16.7M
Put Options Held
14.6M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $408B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email